ArticleMedical oncology (Northwood, London, England)2015

A phase I pilot study of the insulin-like growth factor 1 receptor pathway modulator AXL1717 in combination with gemcitabine HCl and carboplatin in previously untreated, locally advanced, or metastatic non-small cell lung cancer.

Georg Holgersson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.